# BTX-A and Mirror Therapy for Chronic Stroke Spasticity

> **NCT07331844** · NA · COMPLETED · sponsor: **Fatih Sultan Mehmet Training and Research Hospital** · enrollment: 30 (actual)

## Conditions studied

- Stroke
- Spastic Hemiplegia

## Interventions

- **DRUG:** Botulinum toxin type A (Botox®, Allergan)
- **PROCEDURE:** Mirror Therapy
- **PROCEDURE:** Sham Mirror Therapy

## Key facts

- **NCT ID:** NCT07331844
- **Lead sponsor:** Fatih Sultan Mehmet Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-15
- **Primary completion:** 2025-02-15
- **Final completion:** 2025-05-15
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07331844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07331844, "BTX-A and Mirror Therapy for Chronic Stroke Spasticity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07331844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
